Vertebral Column Length to Abdominal Girth Ratio versus Body Mass Index as Predictors of Cephalad Spread of Intrathecal Hyperbaric Levobupivacaine: A Prospective Observational Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: Open Access Original Research Paper Vertebral Column Length to Abdominal Girth Ratio versus Body Mass Index as Predictors of Cephalad Spread of Intrathecal Hyperbaric Levobupivacaine: A Prospective Observational Study Authors: Eliseba Shabong Mawlieh¹, K. Deepa², Dr. Mangesh Suresh Gore³, Dr. Anjana Dinesh Sahu⁴ ¹Senior Resident, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra, India. ²Senior Resident, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra, India. ³Additional Professor, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra, India. ⁴Additional Professor, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra, India. Corresponding Author: K. Deepa, Senior Resident, Topiwala National Medical College and B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra, India. DOI: https://doi.org/10.5281/zenodo.24271404 Received: 01 October 2026, Revised: 16 October 2026, Accepted: 02 November 2026, Online First: 18 November 2026 ABSTRACT Background and Aims: The cephalad spread of intrathecal local anaesthetic is difficult to predict. Vertebral column length (VCL), abdominal girth (AG) and body mass index (BMI) have been proposed as predictors, but data for hyperbaric levobupivacaine in Indian adults are scarce. We compared the VCL/AG ratio with BMI as predictors of sensory block height after a fixed dose of intrathecal hyperbaric levobupivacaine, and examined the effect of sex. Material and Methods: In this prospective observational study, 70 ASA I–II adults (18–60 years) undergoing elective lower abdominal or lower limb surgery received 3 mL (15 mg) of 0.5% hyperbaric levobupivacaine at L3–L4. VCL (C7 to sacral hiatus), AG (at the umbilicus), height and weight were measured before surgery. Sensory level was assessed at 5, 10, 15 and 20 minutes. Heart rate and blood pressure were recorded at baseline and every 5 minutes. Associations were tested with logistic regression (McFadden R²), Pearson correlation and the chi-square test; P < 0.05 was significant. Results: Mean age was 40.9 ± 13.4 years; 37 patients (52.9%) were women. At 20 minutes, 45.7% of patients had a T4 block and 34.3% a T6 block. VCL/AG did not predict block height at any time point (R²McF ≤ 0.0025; P ≥ 0.538). BMI predicted block height at 20 minutes (R²McF = 0.036, P = 0.023) but not earlier. Sex did not affect sensory or motor block (all P > 0.05). Heart rate fell from 86.6 to 78.3 beats/min and systolic pressure from 132 to 118 mmHg over 20 minutes. Conclusion: With a fixed dose of hyperbaric levobupivacaine, BMI was a modest but significant predictor of final sensory block height, whereas the VCL/AG ratio was not. No single anthropometric measure predicted block height reliably. Keywords: Abdominal girth; body mass index; levobupivacaine; spinal anaesthesia; vertebral column length INTRODUCTION Spinal anaesthesia, introduced by Bier in 1898, remains a cornerstone of anaesthesia for lower abdominal, pelvic and lower limb surgery.[1] Compared with general anaesthesia it offers good haemodynamic stability, early mobilisation and lower analgesic requirements.[2] Even so, the height of block reached after a given dose is hard to predict, and the range of intrathecal agents has widened over time.[3] Block height depends on patient characteristics, cerebrospinal fluid (CSF) characteristics, the properties of the local anaesthetic and the technique used. Lumbosacral CSF volume and pressure are major determinants.[4,5] Among patient factors, vertebral column length (VCL), abdominal girth (AG) and body mass index (BMI) have been reported to predict spread.[6,7] A shorter VCL is thought to reflect a smaller subarachnoid space, while a larger AG is a surrogate for raised intra-abdominal pressure, which reduces lumbosacral CSF volume.[8,9] Results have been inconsistent across populations, drugs and measurement methods, and few studies have compared a combined VCL/AG index with BMI. Levobupivacaine, the S(−) enantiomer of bupivacaine, causes less cardiac and central nervous system toxicity than the racemic drug.[10–12] The spread of bupivacaine and ropivacaine has been studied extensively,[13] but data on levobupivacaine are limited.[14] We therefore examined whether the VCL/AG ratio or BMI better predicts the cephalad spread of a fixed 3 mL dose of intrathecal hyperbaric levobupivacaine in Indian adults. Our secondary objective was to compare spread between men and women. MATERIALS AND METHODS Study design and setting: This prospective observational study ran for 18 months in the operating theatres of a tertiary care hospital in Mumbai, India. It was approved by the Institutional Ethics Committee [committee name, approval number and date to be added]. All participants gave written informed consent in a language they understood. Participants: We enrolled adults of either sex, aged 18–60 years, of American Society of Anesthesiologists (ASA) physical status I or II, who were scheduled for elective lower abdominal or lower limb surgery under spinal anaesthesia. We excluded patients with obvious spinal deformity, allergy to local anaesthetics or any component of the formulation, obstetric patients, coagulopathy (platelets < 100,000/mm³ or INR > 1.5), and infection at the injection site. Patients with a failed spinal block (no sensory block or technical failure) were also excluded. Patients were enrolled by convenience sampling until the sample size was reached. Sample size: The sample size was based on a reported Spearman correlation of −0.346 (P = 0.023) between BMI and sensory block height.[15] With a two-sided α of 0.05 and 80% power, the Fisher z-transformation formula gave 63 patients. Allowing for 10% dropout, we enrolled 70. Pre-anaesthetic assessment and measurements: Each patient had a detailed history, general and systemic examination, and baseline heart rate (HR), blood pressure, temperature and oxygen saturation recorded. Before any intervention, one investigator measured the following, with the patient sitting:[4] · Abdominal girth (AG), at the level of the umbilicus at end-expiration (cm) · Vertebral column length (VCL), from the C7 vertebra to the sacral hiatus, without flexion of the back (cm) · Weight (kg) and height (cm) BMI was calculated as weight (kg) divided by height (m) squared, and the VCL/AG ratio was calculated from the two measurements. Anaesthetic technique: All patients were nil by mouth for 8 hours. In the operating room we checked consent and fasting status and applied ECG, non-invasive blood pressure and pulse oximetry monitors. A large-bore intravenous cannula was placed and patients were preloaded with 10 mL/kg of Ringer's lactate. With the patient sitting, the anaesthesiologist performed the subarachnoid block with a 23G Quincke needle at the L3–L4 interspace and injected 3 mL (15 mg) of 0.5% hyperbaric levobupivacaine over 10–15 seconds. Patients were turned supine immediately after injection. Outcomes: The primary outcome was the highest sensory dermatomal level at 5, 10, 15 and 20 minutes after injection, assessed by pinprick and the Hollmann scale [authors to confirm: the Hollmén scale scores motor block, so state the sensory and motor assessment methods separately]. Secondary outcomes were motor block, HR, systolic (SBP), diastolic (DBP) and mean arterial pressure (MAP) at baseline and every 5 minutes, and the difference in spread between men and women. Statistical analysis: Data were analysed with PSPP software. Continuous variables are given as mean ± standard deviation and categorical variables as number (percentage). The association of sensory block level (T12 to T4) with VCL/AG and with BMI at each time point was tested by logistic regression, and goodness of fit is reported as McFadden R² (R²McF). Pearson correlation was used for HR and blood pressure against VCL/AG and BMI. The chi-square test compared sensory and motor block between men and women. A P value below 0.05 was considered significant. RESULTS Patients: Seventy patients were analysed: 37 women (52.9%) and 33 men (47.1%), with 35 in each ASA class. By BMI category, 5 patients (7.1%) were underweight, 29 (41.4%) normal, 17 (24.3%) overweight and 19 (27.1%) obese. Other characteristics are in Table 1. Table 1. Characteristics of the 70 participants Parameter Mean ± SD Median Range Age (years) 40.9 ± 13.4 43.5 18–60 Abdominal girth (cm) 92.3 ± 15.0 91 71–127 Vertebral column length (cm) 51.3 ± 5.17 52 41–60 VCL/AG ratio 0.57 ± 0.111 0.581 0.347–0.797 Weight (kg) 67.4 ± 13.1 66 45–90 Height (cm) 162 ± 8.77 161 148–180 BMI (kg/m²) 25.8 ± 5.51 24.9 15–38.2 Progression of sensory block: The block rose steadily over the 20-minute observation period (Table 2). At 5 minutes most patients were at T12 (40.0%) or T10 (35.7%). At 20 minutes 45.7% had reached T4 and 34.3% T6; only one patient (1.4%) was at T10. Table 2. Highest sensory level over time, n Time after injection T12 T10 T8 T6 T4 5 min 28 (40.0) 25 (35.7) 14 (20.0) 3 (4.3) 0 10 min 9 (12.9) 21 (30.0) 18 (25.7) 17 (24.3) 5 (7.1) 15 min 0 9 (12.9) 18 (25.7) 24 (34.3) 19 (27.1) 20 min 0 1 (1.4) 13 (18.6) 24 (34.3) 32 (45.7) VCL/AG ratio and BMI as predictors: The VCL/AG ratio did not predict sensory level at any time point (R²McF ≤ 0.0025, P ≥ 0.538; Table 3). At 5 minutes the mean ratio was numerically lower in patients at T6 (0.525) than at T12 (0.574), but this was not statistically significant (P = 0.862). BMI was not a significant predictor at 5, 10 or 15 minutes. At 20 minutes it was (R²McF = 0.036, P = 0.023
Language: English
Subfield: Anesthesiology and Pain Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236001261
